Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Laboratory research record on GLP-1S [PMID: 42349668] PubMed laboratory record discussing GLP-1S in a research context
PlexusDx's Microdose GLP-1 Protocol ($129/mo flat) allows patients to start at lower unit amounts and advance at their own pace while maintaining affordability
ATTAIN-1 (NCT05869903) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron at various doses to placebo in adults with obesity, or overweight with at least one of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea or cardiovascular disease, who did not have diabetes
The trial was published in the New England Journal of Medicine and represents the foundational dataset for retatrutide weight loss research
Instead, we connect patients with providers who can write prescriptions for these brands to be filled at a local pharmacy, or for compounded alternatives
US$ 22.06
US$ 25.81
US$ 23.50
US$ 24.75
US$ 22.02
US$ 29.66
